Cargando…

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised

We have raised CD8+ cytotoxic T lymphocytes (CTL) from three Epstein- Barr virus-seropositive donors by incubating peripheral blood lymphocytes with irradiated autologous B95.8-strain EBV-transformed B lymphoblastoid cells (LCL). However, to detect lysis in a standard 51Cr release assay of the LCL a...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1995
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192040/ https://www.ncbi.nlm.nih.gov/pubmed/7539044

Ejemplares similares

Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells
por: Markasz, Laszlo, et al.
Publicado: (2006)

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
por: Hui-Yuen, Joyce, et al.
Publicado: (2011)

Dendrosomal nanocurcumin prevents EBV-associated cell transformation by targeting the lytic cycle genes of the Epstein-Barr virus in the generation of lymphoblastoid cell line
por: Cheragh, Mahboobeh, et al.
Publicado: (2023)

Evidence for the Presentation of Major Histocompatibility Complex Class I–restricted Epstein-Barr Virus Nuclear Antigen 1 Peptides to CD8(+) T Lymphocytes
por: Voo, Kui Shin, et al.
Publicado: (2004)

Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines
por: Chaiwongkot, Arkom, et al.
Publicado: (2020)

Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines
por: Chaiwongkot, Arkom, et al.
Publicado: (2021)

The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4
Publicado: (1996)

Induction of p16(INK4a) Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
por: Skalska, Lenka, et al.
Publicado: (2013)

Induction of epstein-barr virus (EBV) lytic cycle in vitro causes lipid peroxidation, protein oxidation and DNA damage in lymphoblastoid B cell lines
por: Gargouri, Bochra, et al.
Publicado: (2011)

Epstein-Barr Virus- (EBV-) Immortalized Lymphoblastoid Cell Lines (LCLs) Express High Level of CD23 but Low CD27 to Support Their Growth
por: Yap, Hooi-Yeen, et al.
Publicado: (2019)

Recognition of carbohydrate by major histocompatibility complex class I- restricted, glycopeptide-specific cytotoxic T lymphocytes
Publicado: (1994)

Epstein-Barr virus (EBV)-associated miRNAs are important for the maintenance of EBV transformed B cells
por: Linnstaedt, Sarah, et al.
Publicado: (2010)

Correction: Induction of p16(INK4a) Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
por: Skalska, Lenka, et al.
Publicado: (2013)

Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome
por: Torti, Lorenza, et al.
Publicado: (2012)

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
por: Iizasa, Hisashi, et al.
Publicado: (2012)

Epstein–Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV
por: Venturini, Cristina, et al.
Publicado: (2021)

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004)

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies
Publicado: (1992)

Class I major histocompatibility complex-restricted T lymphocyte recognition of the influenza hemagglutinin. Overlap between class I cytotoxic T lymphocytes and antibody sites
Publicado: (1989)

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)
Publicado: (1990)

Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice
por: Gregorovic, Goran, et al.
Publicado: (2015)

COMPARISON OF THE YIELD OF INFECTIOUS VIRUS FROM CLONES OF HUMAN AND SIMIAN LYMPHOBLASTOID LINES TRANSFORMED BY EPSTEIN-BARR VIRUS
por: Miller, George, et al.
Publicado: (1973)

Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines
por: Lee, Dong Hyeon, et al.
Publicado: (2006)

Prognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemia
por: Liang, Jin-Hua, et al.
Publicado: (2015)

Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants
Publicado: (1983)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

Decrypting the structure of major histocompatibility complex class I- restricted cytotoxic T lymphocyte epitopes with complex peptide libraries
Publicado: (1995)

Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis
por: Pender, M P, et al.
Publicado: (2009)

Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines
por: Kotaki, Ryutaro, et al.
Publicado: (2020)

Idiotypes on major histocompatibility complex-restricted virus-immune cytotoxic T lymphocytes
Publicado: (1981)

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
por: Mika, Thomas, et al.
Publicado: (2019)

Epstein–Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact
por: Carpén, Timo, et al.
Publicado: (2020)

Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
por: Ahmed, Naveed, et al.
Publicado: (2022)

Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers
por: Teow, Sin-Yeang, et al.
Publicado: (2017)

Molecular Epidemiology of Epstein-Barr virus (EBV) in Patients with Hematologic Malignancies
por: Tabibzadeh, Alireza, et al.
Publicado: (2020)

Prevalence of Epstein–Barr virus (EBV) in Iranian Breast Carcinoma Patients
por: Golrokh Mofrad, Morvarid, et al.
Publicado: (2020)

An Acute Presentation of Epstein-Barr Virus (EBV) Infection in an Immunocompromised Gentleman
por: Bhattacharjee, Shaumick, et al.
Publicado: (2022)

Association of Epstein-Barr virus (EBV) with lung cancer: meta-analysis
por: Chen, Yizhuo, et al.
Publicado: (2023)

Epstein–Barr Virus Genetic Variation in Lymphoblastoid Cell Lines Derived from Kenyan Pediatric Population
por: Simbiri, Kenneth O., et al.
Publicado: (2015)

Efficient and reliable establishment of lymphoblastoid cell lines by Epstein-Barr virus transformation from a limited amount of peripheral blood
por: Omi, Natsue, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3ih327i6dhnmqlqk4h8drs2clj